Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Congress Center Basel

Apr 17, 2018 2:00 PM - Apr 19, 2018 11:00 PM

Messeplatz 21 , CH-4021 Basel , SWITZERLAND

DIA EUROPE 2018

Major Reforms and Strengthened International Cooperation – What Is Happening in China?

Session Chair(s)

Carol  Zhu, MBA

Carol Zhu, MBA

Vice President, Portfolio and Project Management

JW Therapeutics, China

The Chinese legal framework for medical products has undergone major reforms in the last years. The new pieces of legislation are now coming into force one by one. It is most relevant for companies to be abreast with the changes the new legislation brings for this important market. In addition, the China Food and Drug Administration has strengthened and enhanced its international cooperation. The underlying strategy as well as some recent developments will be outlined, such as the role and involvement of CFDA in ICH and ICMRA.

Speaker(s)

Xiaoling  Qin

China Regulatory Reform in Review and Approval and Global Collaboration

Xiaoling Qin

National Medical Products Administration, China

Director, Department of the Science & Technology & International Cooperation

Xiangyu  Wang

Xiangyu Wang

Division Director, Department of International Cooperation, China

Xiaojun (Wendy)  Yan, MD, MBA

New Approaches from China Regulatory Authority to Foster Innovation - Industry Perspective

Xiaojun (Wendy) Yan, MD, MBA

BeiGene (Beijing) Co., Ltd., China

Senior Vice President, Senior Advisor

Melly  Lin, MS

Panel Discussion

Melly Lin, MS

F. Hoffmann-La Roche Ltd, Switzerland

CMC Regulatory Policy Lead, Pharma Technical Regulatory

Jessica  Liu, MD

Panel Discussion

Jessica Liu, MD

Tigermed Consulting Co., Ltd, China

VP, Head of Merges and Acquisition Management Department

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.